163 Results for "

casein Kinase

" in MedChemExpress (MCE) Product Catalog:
Products (163)

163 Results for "casein Kinase" in MCE Product Catalog:

1199
1199 Publications Verification
Cat. No.: HY-10108A
CAS No.: 934389-88-5
Purity:  99.93%
Research Areas:  

Cancer

LY294002 hydrochloride is a potent and broad-spectrum PI3K inhibitor, with IC50 values of 0.5, 0.57, and 0.97 μM for P110α, P110δ and P110β, respectively. LY294002 hydrochloride also inhibits CK2 with an IC50 of 98 nM. LY294002 hydrochloride can be used for pancreatic cancer research .
loading...
    loading...
192
192 Cited Publications
Cat. No.: HY-15979
CAS No.: 127243-85-0
Target:  

PKA Autophagy

Research Areas:  

Neurological Disease

H-89 is a potent and selective inhibitor of cyclic AMP-dependent protein kinase (protein kinase A) with IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase, and others kinases.
loading...
    loading...
192
192 Cited Publications
Cat. No.: HY-15979A
CAS No.: 130964-39-5
Target:  

PKA Autophagy

Research Areas:  

Others

H-89 dihydrochloride is a potent and selective inhibitor of protein kinase A (PKA) with an IC50 of 48 nM and has weak inhibition on PKG, PKC, Casein Kinase.
loading...
    loading...
42
42 Cited Publications
Cat. No.: HY-14393
CAS No.: 518-82-1
Purity:  99.25%
Synonyms: Frangula emodin
Emodin (Frangula emodin), an anthraquinone derivative, is an anti-SARS-CoV compound. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 (ACE2) interaction . Emodin inhibits casein kinase-2 (CK2). Anti-inflammatory and anticancer effects . Emodin is a potent selective 11β-HSD1 inhibitor with the IC50 of 186 and 86 nM for human and mouse 11β-HSD1, respectively. Emodin ameliorates metabolic disorder in diet-induced obese mice .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-14394
CAS No.: 17374-26-4
Purity:  98.54%
Synonyms: NSC 231634; casein Kinase II Inhibitor I
Target:  

Casein Kinase

Research Areas:  

Cancer

TBB is a cell-permeable and ATP-competitive CK2 inhibitor with an IC50 of 0.15 μM for rat liver CK2.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-10324
CAS No.: 301836-43-1
Purity:  99.94%
Synonyms: casein Kinase I Inhibitor
Research Areas:  

Cancer

D4476 is a potent, selective and cell-permeable inhibitor of casein kinase 1(CK1) with an IC50 value of 0.3 μM in vitro.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-10456
CAS No.: 303162-79-0
Purity:  99.76%
Target:  

p38 MAPK Casein Kinase Wnt

Research Areas:  

Inflammation/Immunology

TAK-715 is an orally active and potent p38 MAPK inhibitor with IC50s of 7.1 nM, 200 nM for p38α and p38β, respectively. TAK-715 inhibits casein kinase I (CK1δ/ε) to regulate activation of Wnt/β-catenin signaling. TAK-715 shows good significant efficacy in a rat arthritis model .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-14392
CAS No.: 53-85-0
Purity:  99.89%
Synonyms: DRB
Target:  

CDK Apoptosis

Research Areas:  

Cancer

5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-15535
CAS No.: 749234-11-5
Purity:  98.09%
Synonyms: CK2 Inhibitor; casein Kinase II Inhibitor
Target:  

Casein Kinase

Research Areas:  

Cancer

DMAT is a potent and specific CK2 inhibitor with an IC50 value of 130 nM.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-15490
CAS No.: 950912-80-8
Purity:  99.96%
Target:  

Casein Kinase

Research Areas:  

Cancer

PF-670462 dihydrochloride is a potent and selective inhibitor of casein kinase (CK1ε and CK1δ), with IC50s of 7.7 nM and 14 nM, respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-12279
CAS No.: 1532533-67-7
Purity:  98.94%
Synonyms: TGR-1202; RP5264
Target:  

PI3K Casein Kinase

Research Areas:  

Cancer

Umbralisib (TGR-1202) is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib can be used for haematological malignancies reseach .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-12279C
CAS No.: 1532533-78-0
Purity:  99.04%
Synonyms: TGR-1202 hydrochloride; RP5264 hydrochloride
Target:  

PI3K Casein Kinase

Research Areas:  

Cancer

Umbralisib (TGR-1202) hydrochloride is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib hydrochloride exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib hydrochloride can be used for haematological malignancies reseach .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-12470
CAS No.: 1188296-52-7
Purity:  99.69%
Target:  

Casein Kinase

Research Areas:  

Others

PF-4800567 is a potent and selective inhibitor of casein kinase 1? (CK1?), with an IC50 of 32 nM, which is greater than 20-fold selectivity over CK1δ (IC50, 711 nM).
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1821
CAS No.: 126768-94-3
Synonyms: MHP4-14
Target:  

PKC

Research Areas:  

Neurological Disease

Myelin Basic Protein (MHP4-14), a synthetic peptide comprising residues 4-14 of myelin basic protein, is a very selective PKC substrate (Km=7 μM). Myelin Basic Protein is not phosphorylated by cyclic AMP-dependent protein kinase, casein kinases I and II, Ca 2+/calmodulin-dependent protein kinase II, or phosphorylase kinase, and can be routinely used for the assay of protein kinase C with low background in the crude tissue extracts .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108606
CAS No.: 942289-87-4
Purity:  99.62%
Target:  

PI3K Casein Kinase

Research Areas:  

Cancer

PI-828 is a dual PI3K and casein kinase 2 (CK2) inhibitor with IC50s of 173 nM, 149 nM, and 1127 nM for p110α, CK2, and CK2α2 in lipid kinase assay, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-120675
CAS No.: 1242422-09-8
Purity:  99.37%
Target:  

Casein Kinase Wnt

Research Areas:  

Cancer

SSTC3 is a casein kinase 1α (CK1α) activator (Kd = 32 nM) that inhibits WNT signaling (EC50 = 30 nM). SSTC3 exhibits minimal gastrointestinal toxicity compared to other classes of WNT inhibitors .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P3815
CAS No.: 132176-35-3
Target:  

Casein Kinase

Research Areas:  

Others

Casein Kinase 2 Substrate Peptide is a common CK2 substrate peptide. Casein Kinase 2 Substrate Peptide is synthesized with its C-terminus conjugated to 5-[(2-aminoethyl)amino]naphthalene-1-sulfonic acid (EDANS). Casein Kinase 2 Substrate Peptide can be used for protein kinase CK2 activity determination .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1821A
Synonyms: MHP4-14 TFA
Target:  

PKC

Research Areas:  

Neurological Disease

Myelin Basic Protein (MHP4-14) TFA, a synthetic peptide comprising residues 4-14 of myelin basic protein, is a very selective PKC substrate (Km=7 μM). Myelin Basic Protein TFA is not phosphorylated by cyclic AMP-dependent protein kinase, casein kinases I and II, Ca 2+/calmodulin-dependent protein kinase II, or phosphorylase kinase, and can be routinely used for the assay of protein kinase C with low background in the crude tissue extracts .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-115519
CAS No.: 694522-87-7
Purity:  98.98%
Target:  

Casein Kinase

Research Areas:  

Cancer

(E/Z)-GO289 is a potent and selective casein kinase 2 (CK2) inhibitor (IC50=7 nM). (E/Z)-GO289 strongly lengthens circadian period. (E/Z)-GO289 exhibits cell type–dependent inhibition of cancer cell growth that correlated with cellular clock function .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-18758
CAS No.: 868612-83-3
Target:  

TGF-β Receptor

Research Areas:  

Inflammation/Immunology Cancer

IN-1130 is a highly selective transforming growth factor-β type I receptor kinase (ALK5) inhibitor with an IC50 of 5.3 nM for ALK5-mediated Smad3 phosphorylation. IN-1130 inhibits ALK5 phosphorylation of casein (IC50=36 nM) and p38α mitogen-activated protein kinase (IC50=4.3 μM). IN-1130 suppresses renal fibrosis in obstructive nephropathy and blocks breast cancer lung metastasis .
loading...
    loading...